Navigation Links
BioAnalytix advances the biologic drug development
Date:6/11/2014

Biologic drugs are highly complex, but they may be the answer to many medical illnesses and conditions that currently have no treatment available. The problem is, these drugs are not easy to characterize and test. Unlike most drugs that are chemically synthesized, biological products are protein-based and biologically produced. This means the drug development and testing stages are often much longer and more complex.

To answer this need, Northeastern University's College of Science and the Barnett Institute launched BioAnalytix two years ago. Led by CEO Kirtland Poss, BioAnalytix is now filling a critical gap in the area of biologic drug development and launch. "What we do is unique and in demand," said Poss. "There is a lot of complexity to biologic drugs, and they need precise characterization throughout the development process and it's hard to do."

For the past 10 years, the Barnett Institute has been applying its characterization techniques to biologic drugs in early stage development. In 2012, BioAnaytix was formed to help with the later-stage development decisions and regulatory filings for these cutting-edge drugs.

Currently, BioAnalytix is working with leading pharmaceutical companies in the U.S, Europe, and Asia, typically on later stage drug development. This is the stage where a biologic drug looks promising, and the drug company is looking to move on to Phase 3 clinical trials or regulatory approvalsthe final stages before going on the market.

Over the past year, BioAnalytix has made some very significant progress. The company is hiring an industry-seasoned CFO, and has also moved to Cambridge, where it is surrounded by many leading pharmaceutical companies, but is still close to its original home, the Barnett Institute.

"BioAnaytix will continue to maintain and grow its affiliation with Northeastern University and the Barnett, because it is a very natural and real win for both of us," said Poss. "They benefit from more exposure to pharmaceutical companies, and we benefit from exposure to cutting-edge innovation and early stage research that is truly world-leading in these areas. As we grow, this will continue to benefit both."


'/>"/>

Contact: Lori Lennon
l.lennon@neu.edu
617-680-5129
Northeastern University College of Science
Source:Eurekalert

Related medicine news :

1. Northeasterns Barnett Institute announces formation of leading analytics company, BioAnalytix, LLC
2. Major advances in breast, prostate, colorectal cancer featured at ASCO Annual Meeting
3. EuroPCR 2014 showcases technological advances in complex cardiovascular interventions
4. Molecule linked to aggressive pancreatic cancer offers potential clinical advances
5. Space-tested fluid flow concept advances infectious disease diagnoses
6. Smartphone app reads blood oxygen levels to hospital standards, advances to global obstetrics tests
7. Autism Speaks study finds advances towards universal early screening
8. WesternU Team Advances Understanding of Mechanisms of Learning and Neural Degeneration
9. New Advances in Oral Technology from Henning Family Dental in Spokane Create Comfort for Anxious Patients
10. Enterprises TV Introduces New Series on Nutritional Advances
11. Autism Speaks announces top 10 advances in autism research 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2017)... ... August 19, 2017 , ... The digital health ... organization with pending recognition status from the Centers for Disease Control and Prevention ... classes and live video conferencing. , The DPP resulted from clinical work ...
(Date:8/19/2017)... ... August 19, 2017 , ... Physician ... its Orlando location as an interventional pain management physician. He brings a wealth ... treatment of migraine headaches, and significant experience in spinal cord stimulation for chronic ...
(Date:8/18/2017)... New York, New York (PRWEB) , ... ... ... Q International Courier, LLC, d/b/a Quick International, LLC (“Quick”), a highly specialized ... today announced it has entered into a definitive agreement to purchase Unitrans ...
(Date:8/18/2017)... ... ... The Dawn Johnson Insurance Group, a Missouri-based insurance and financial planning firm ... for efforts to educate the local population on cancer realities while attracting donations to ... , Each day in America, roughly 4,600 new cases of cancer are diagnosed and ...
(Date:8/18/2017)... ... , ... The Brian Gifford Agency, an Indiana-based firm providing asset protection and ... Academy in a charity drive to provide for at-risk children and teens in the ... is a nonprofit organization that has offered critical programs to at-risk and foster children ...
Breaking Medicine News(10 mins):
(Date:8/2/2017)... Ore. , Aug. 2, 2017  Life Flight Network ... Agreement. The agreement improves patient care and operational efficiency for ... Springfield , Cottage Grove , ... level medical transportation. PeaceHealth and Life Flight Network work collaboratively ... available during transport, or when a time sensitive emergency exists. ...
(Date:7/31/2017)...  Diplomat Pharmacy, Inc. (NYSE: DPLO), has been named one ... by Crain,s Detroit Business . The annual ... three-year revenue growth. This year,s edition measures growth from 2013 ... the complete list, visit crainsdetroit.com/awards/fast_50/2017 .  ... said Phil Hagerman , CEO and chairman of Diplomat. ...
(Date:7/28/2017)... July 28, 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") ... third quarter ended June 30, 2017, and updated its ... For the fiscal third quarter, Hill-Rom ... $0.68 per diluted share in the prior-year period. These ... $0.39 per diluted share primarily related to the non-cash ...
Breaking Medicine Technology: